Akari Therapeutics's top three insider shareholders as of September 29, 2026 are Samir Rashmikant Patel (Director, 131.24Mn shares), Raymond Prudo-Chlebosz (Director, 101.93Mn shares), Rachelle Suzanne Jacques (Chief Executive Officer, 25.45Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Samir Rashmikant Patel | Director, TenPercentOwner | 0 | 131,336,029 | 131,336,029 | 49.5% | 17 Jul, 2026 |
| 2 | Raymond Prudo-Chlebosz | Director | 101,990,240 | 0 | 101,990,240 | 38.4% | 10 Mar, 2025 |
| 3 | Rachelle Suzanne Jacques | Chief Executive Officer | 25,450,695 | 0 | 25,450,695 | 9.6% | 30 Apr, 2024 |
| 4 | Wendy F Dicicco | Interim Cfo | 3,961,848 | 0 | 3,961,848 | 1.5% | 03 May, 2024 |
| 5 | Abizer Gaslightwala | Ceo | 1,801,652 | 0 | 1,801,652 | 0.7% | 29 Aug, 2025 |
| 6 | James R Neal | Director | 806,307 | 0 | 806,307 | 0.3% | 10 Mar, 2025 |
| 7 | Hoyoung Huh | Director, TenPercentOwner | 117,396 | 0 | 117,396 | 0.0% | 10 Mar, 2025 |
| 8 | Kameel D. Farag | Interim Cfo | 23,309 | 0 | 23,309 | 0.0% | 19 Aug, 2026 |
| 9 | Sandip I Patel | Director | 12,412 | 0 | 12,412 | 0.0% | 29 Apr, 2025 |
| 10 | Robert B Bazemore | Director | 1,116 | 0 | 1,116 | 0.0% | 10 Mar, 2025 |
| 11 | Torsten Hombeck | Cfo | 5 | 0 | 5 | 0.0% | 13 Jan, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 17 Aug, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 1,728 | $7.52 | $12.99K | 23,309 | Direct |
| 16 Jul, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 1,130 | $11.50 | $13.00K | 21,581 | Direct |
| 07 Jul, 2026 | Samir Rashmikant Patel | Director, TenPercentOwner | Acquired M | 1,209 | $8.00 | $9.67K | 76,976 | Indirect |
| 07 Jul, 2026 | Samir Rashmikant Patel | Director, TenPercentOwner | Acquired M | 15,466 | $0.00 | $6 | 92,442 | Indirect |
| 07 Jul, 2026 | Samir Rashmikant Patel | Director, TenPercentOwner | Acquired M | 5,799 | $0.00 | $2 | 98,241 | Indirect |
| 07 Jul, 2026 | Samir Rashmikant Patel | Director, TenPercentOwner | Acquired M | 1,209 | $32.00 | $38.69K | 0 | Indirect |
| 07 Jul, 2026 | Samir Rashmikant Patel | Director, TenPercentOwner | Acquired M | 15,466 | $16.16 | $249.93K | 0 | Indirect |
| 07 Jul, 2026 | Samir Rashmikant Patel | Director, TenPercentOwner | Acquired M | 5,799 | $16.16 | $93.71K | 0 | Indirect |
| 24 Jun, 2026 | Abizer Gaslightwala | Ceo | Acquired A | 5,500 | $0.00 | $0 | 5,500 | Direct |
| 24 Jun, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 1,248 | $10.02 | $12.50K | 2,870 | Direct |
| 24 Jun, 2026 | Abizer Gaslightwala | Ceo | Acquired A | 15,563 | $0.00 | $0 | 15,563 | Direct |
| 24 Jun, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 1,395 | $9.32 | $13.00K | 4,265 | Direct |
| 24 Jun, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 1,570 | $8.28 | $13.00K | 5,835 | Direct |
| 24 Jun, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 2,539 | $5.12 | $13.00K | 8,374 | Direct |
| 24 Jun, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 3,725 | $3.49 | $13.00K | 12,099 | Direct |
| 24 Jun, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 7,353 | $3.74 | $27.50K | 19,452 | Direct |
| 24 Jun, 2026 | Kameel D. Farag | Interim Cfo | Acquired A | 1,000 | $13.00 | $13.00K | 20,452 | Direct |
| 16 Dec, 2025 | Samir Rashmikant Patel | Director, TenPercentOwner | Acquired P | 618,658 | — | — | 15,466 | Direct |
| 16 Dec, 2025 | Hoyoung Huh | Director, TenPercentOwner | Acquired P | 618,658 | — | — | 15,466 | Direct |
| 16 Dec, 2025 | Robert B Bazemore | Director | Acquired P | 123,731 | — | — | 3,093 | Direct |